Form 4: Albemarle Director James O'Brien Receives Annual Stock Compensation

Albemarle Corporation's Director, James J. O'Brien, acquired 2,762 shares of common stock through annual compensation and dividend reinvestment, increasing his direct beneficial ownership to 8,085 shares.

Summary

• James J. O'Brien, a Director of Albemarle Corporation, acquired 2,725 shares of common stock on July 1, 2025, as an annual installment of non-employee director stock compensation under the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors.
• These 2,725 shares are scheduled to vest on July 1, 2026.
• Additionally, Mr. O'Brien acquired 37 shares of common stock on July 1, 2025, representing dividends accrued on a previous award granted on July 1, 2024, which vested in full on July 1, 2025, and were settled in shares under the 2023 Directors Plan.
• Following these transactions, Mr. O'Brien's direct beneficial ownership of Albemarle common stock increased to 8,085 shares.
• The acquisitions were made at a price of $0 per share, indicating they were compensation or dividend distributions rather than open market purchases.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it reflects routine director compensation, which aligns director interests with shareholders, a generally favorable corporate governance practice. It is not highly impactful but is a standard positive signal.

Positives

• The acquisition of shares by a director through compensation aligns their interests with those of shareholders, promoting long-term value creation.
• The use of stock compensation is a common practice that helps retain experienced board members.

Future Outlook

The 2,725 shares of common stock acquired as part of the annual director compensation are scheduled to vest on July 1, 2026.

Industry Context

Stock-based compensation for non-employee directors is a standard practice across publicly traded companies, including those in the specialty chemicals and materials sector like Albemarle, as it aligns director interests with shareholder value and incentivizes long-term performance.

Comparison to Industry Standards

• The practice of providing stock-based compensation to non-employee directors, as seen with James J. O'Brien's share acquisition, is a common and widely accepted corporate governance practice across various industries, including the chemical and materials sector where Albemarle operates.
• This method of compensation is consistent with global benchmarks for director remuneration, aiming to align the financial interests of board members directly with the long-term performance and shareholder value of the company.

Corporate Governance

Related Party Transactions

• The acquisition of common stock by Director James J. O'Brien as compensation is a related party transaction, executed under the company's 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors.

Stakeholder Impact

• Shareholders: The stock compensation aligns the financial interests of the director with those of the shareholders, potentially fostering decisions that enhance long-term shareholder value.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The 2,725 shares of common stock acquired on July 1, 2025, are expected to vest on July 1, 2026.

Key Dates

Keywords

Albemarle, ALB, SEC Form 4, Insider Transaction, Director Compensation, Stock Award, Common Stock, Corporate Governance, Equity Compensation